CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2020; 10(01): 03-08
DOI: 10.1055/s-0040-1709959
Review Article

Cancer Theranostics: Bridging Conventional and Nano-photodynamic Therapy

Poorani Gananathan
1   Nitte (Deemed to be) University, University Enclave, Deralakatte, Mangalore, Karnataka, India
,
Anirban Chakraborty
2   Nitte University Centre for Science Education & Research, Nitte (Deemed to be) University, Deralakatte, Mangalore, Karnataka, India
,
Indrani Karunasagar
2   Nitte University Centre for Science Education & Research, Nitte (Deemed to be) University, Deralakatte, Mangalore, Karnataka, India
› Author Affiliations

Abstract

Cancer is of various kinds, so are the treatment modalities. Worldwide, cancer is the second leading cause of death, accounting for a whopping 9.6 million deaths in 2018. Globally, approximately one in six deaths is attributed to cancer. Photodynamic therapy (PDT) is a therapeutic strategy for the treatment of superficial lesions, warts, Barrett’s esophagus, premalignant lesions, malignant tumors, and ophthalmic diseases. The literature on PDT is approximately one-third of that in radiation therapy, yet the clinical implementation of PDT in cancer is relatively less. Despite substantial research, the clinical application of photodynamic strategy in cancer therapy is still in its infancy with only a limited number of case studies reported so far. The limitations of the photosensitizer and the shallow depth of penetration of light source are the key technical impediments. However, the use of nanomedicine in PDT can overcome these obstacles. Thus, it is necessary to gain knowledge on how nanomaterials can be merged with PDT and how it can be utilized in cancer theranostics. In this article, the focus is to understand how PDT works and how it can be utilized in improving the sensitivity of the existing diagnostic and therapeutic techniques. The article also addresses the current challenges for PDT and the future prospects of this technique, particularly in the area of diagnosis and treatment of cancer.



Publication History

Article published online:
20 April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res 2003; 23 (5A) 3591-3600
  • 2 Sellera FP, Nascimento CL, Ribeiro MS. eds Photodynamic Therapy in Veterinary Medicine: From Basics to Clinical Practice. Switzerland: Springer International Publishing; 2016
  • 3 Moan J, Peng Q. An outline of the history of PDT. Photodynam Therap 2003; 1-18 DOI: 10.1039/9781847551658-00001.
  • 4 Benov L. Photodynamic therapy: current status and future directions. Med Princ Pract 2015; 24 (Suppl. 01) 14-28
  • 5 Akimoto J, Fukami S, Ichikawa M, Mohamed A, Kohno M. Intraoperative photodiagnosis for malignant glioma using photosensitizer talaporfin sodium. Front Surg 2019; 6: 12
  • 6 Agostinis P, Berg K, Cengel KA. et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 4250-4281
  • 7 Cengel KA, Simone II CB, Glatstein E. PDT: what’s past is prologue. Cancer Res 2016; 76 (09) 2497-2499
  • 8 Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001; 74 (05) 656-669
  • 9 Kessel D. Introduction to photodynamic therapy. Available at: http://photobiology.info/Kessel.html. Accessed march 27, 2020
  • 10 Evensen JF. The use of porphyrins and non-ionizing radiation for treatment of cancer. Acta Oncol 1995; 34 (08) 1103-1110
  • 11 Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3 (05) 380-387
  • 12 Wiedmann MW, Caca K. General principles of photodynamic therapy (PDT) and gastrointestinal applications. Curr Pharm Biotechnol 2004; 5 (04) 397-408
  • 13 Mayor PC, Lele S. Photodynamic therapy in gynecologic malignancies: a review of the roswell park cancer institute experience. Cancers (Basel) 2016; 8 (10) E88
  • 14 Photodynamic Therapy. Available at: https://www.aetnabetterhealth.com/pennsylvania/assets/pdf/provider/guidelines/medical/Medical/Photodynamic-Therapy.pdf. Accessed April 12, 2020
  • 15 Shackley DC, Whitehurst C, Clarke NW, Betts C, Moore JV. Photodynamic therapy. J R Soc Med 1999; 92 (11) 562-565
  • 16 da Silva NS, Costa MM, Soares CP. Photodynamic therapy: porphyrins and phthalocyanines as photosensitizers. Aust J Chem 2008; 61: 741-754
  • 17 Schreurs TJL, Jacobs I, Nicolay K, Prompers JJ, Strijkers GJ. Detection of treatment success after photodynamic therapy using dynamic contrast-enhanced magnetic resonance imaging. Theranostics 2017; 7 (19) 4643-4657
  • 18 Henderson BW, Waldow SM, Potter WR, Dougherty TJ. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo. Cancer Res 1985; 45 (12, Pt 1) 6071-6077
  • 19 Celli JP, Spring BQ, Rizvi I. et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010; 110 (05) 2795-2838
  • 20 Kudinova NV, Berezov TT. Photodynamic therapy of cancer: search for ideal photosensitizer. Biochemistry Supplement Series B: Biomedical Chemistry. T.T.Biochem. Moscow Suppl. Ser. B. Springer International Publishing, Switzerland 2010; 4 (01) 95-103
  • 21 Allison RR, Downie GH, Cuenca R, Hu XH, Childs CJ, Sibata CH. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther 2004; 1 (01) 27-42
  • 22 Rishi P, Agarwal V. Current role of photodynamic therapy in ophthalmic practice. Sci J Med & Vis Res Foun 2015; 33: 2
  • 23 Mahalingam SM, Ordaz JD, Low PS. Targeting of a photosensitizer to the mitochondrion enhances the potency of photodynamic therapy. ACS Omega 2018; 3 (06) 6066-6074
  • 24 Wang P, Tang H, Zhang P. Plasmonic nanoparticle-based hybrid photosensitizers with broadened excitation profile for photodynamic therapy of cancer cells. Sci Rep 2016; 6: 34981
  • 25 Banerjee HN, Verma M. Application of nanotechnology in cancer. Technol Cancer Res Treat 2008; 7 (02) 149-154
  • 26 Ghatole S, Dahikar PB, Rokde K. Study of biosensors using nanotechnology. Int J Adv Sci Eng Technol 2015; (01) 155-157 ISSN:2321–9009
  • 27 Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol 2018; 9: 1050-1074
  • 28 Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev 2006; 35 (07) 583-592
  • 29 Poorani G, Rao AP, Singaravelu G, Manickam E. Review of laser in nanophotonics – a literature study for cellular mechanism. J Cancer Biol Res 2017; 5 (01) 1094
  • 30 Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology 2004; 2 (01) 3
  • 31 Behzadi S, Serpooshan V, Tao W. et al. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev 2017; 46 (14) 4218-4244
  • 32 Wang EC, Wang AZ. Nanoparticles and their applications in cell and molecular biology. Integr Biol 2014; 6 (01) 9-26
  • 33 Mesquita MQ, Dias CJ, Gamelas S, Fardilha M, Neves MGPS, Faustino MAF. An insight on the role of photosensitizer nanocarriers for photodynamic therapy. An Acad Bras Cienc 2018; 90 (01) (Suppl. 02) 1101-1130
  • 34 Popp J, Tuchin VV, Chiou A, Heinemann S. Handbook of Biophotonics: Photonics for Health Care. Weinheim, Germany: Wiley-VCH Verlag and Co; 2012: 321-336
  • 35 Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J 2016; 473 (04) 347-364
  • 36 Calderhead RG, Tanaka Y. Photobiological Basics and Clinical Indications of Phototherapy for Skin Rejuvenation. Photomedicine - Advances in Clinical Practice. London, United Kingdom: Intech open; 2017: 215-252
  • 37 Al-Omari S. Toward a molecular understanding of the photosensitizer-copper interaction for tumor destruction. Biophys Rev 2013; 5 (04) 305-311
  • 38 Shahbazi M-A, Herranz B, Santos HA. Nanostructured porous Si-based nanoparticles for targeted drug delivery. Biomatter 2012; 2 (04) 296-312
  • 39 Golombek SK, May JN, Theek B. et al. Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 2018; 130: 17-38
  • 40 Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006; 6 (04) 662-668
  • 41 Li Y, Wei Q, Ma F, Li X, Liu F, Zhou M. Surface-enhanced Raman nanoparticles for tumor theranostics applications. Acta Pharm Sin B 2018; 8 (03) 349-359
  • 42 Anker JN, Hall WP, Lyandres O. Shah NC, Zhao J, Van Duyne RP. Biosensing with plasmonic nanosensors. Nat Mater 2008; 7 (06) 442-453
  • 43 Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1 (03) 325-327